Fig. 2From: Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinraChange in level of C-reactive protein (CRP) with anakinra treatment after 30 months of follow-up. Vertical discontinued line indicated the introduction time of anakinra. CRP rapidly decreases 1 month after initiation of the IL-1Ra treatment. CRP was normalized and stabilized during the follow-upBack to article page